Concepedia

Yuichi Akatsu

YA

Statistics

Publications

6

Citations

370

H-Index

6

Active since

2011

Affiliations

The University of Tokyo(Current)

Japan Science and Technology Agency

Nippon Kayaku (Japan)

Tokyo Medical and Dental University

Yuichi Akatsu is an author at The University of Tokyo specializing in signal transduction, cell signaling, and growth factor signaling.

Publications per year

2011–2020

6

Publications

6

Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression

Yasuhiro Yoshimatsu, Yulia G. Lee, Yuichi Akatsu et al. · Proceedings of the National Academy of Sciences · 2013 · 110 citations · Full text

Medicine, Cancer Biology, Oncology +15

TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A

Hajime Mihira, Hiroshi Suzuki, Yuichi Akatsu et al. · The Journal of Biochemistry · 2011 · 105 citations

Life Sciences, Molecular Biology, Physiology +11

Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1

Yuichi Akatsu, Naoya Takahashi, Yasuhiro Yoshimatsu et al. · Molecular Oncology · 2019 · 53 citations · Full text

Medicine, Cell Biology, Oncology +17

Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer

Kazuki Takahashi, Yuichi Akatsu, Katarzyna A. Podyma‐Inoue et al. · Journal of Biological Chemistry · 2020 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Novel Compound, NK150460, Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor

Kazuteru Fukasawa, Shigehide Kagaya, Sakiko Maruyama et al. · Molecular Cancer Therapeutics · 2014 · 26 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 6